{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:47:00Z","timestamp":1786117620879,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Pharmaceuticals Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xkme.2026.101412","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:49:28Z","timestamp":1778831368000},"page":"101412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study"],"prefix":"10.1016","volume":"8","author":[{"given":"Sijia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101412_bib1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"56","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.xkme.2026.101412_bib2","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101412_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101412_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3122\/jabfm.2009.05.090026","article-title":"Secondary hyperparathyroidism: pathophysiology and treatment","volume":"22","author":"Saliba","year":"2009","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101412_bib5","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.xkme.2026.101412_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ckj\/sfx125","article-title":"Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes","volume":"11","author":"Pereira","year":"2018","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.xkme.2026.101412_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1744-9987.14125","article-title":"Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: a systematic review and meta-analysis of randomized studies","volume":"28","author":"Nakai","year":"2024","journal-title":"Ther Apher Dial"},{"issue":"5","key":"10.1016\/j.xkme.2026.101412_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1592\/phco.25.5.709.63595","article-title":"Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"25","author":"Byrnes","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.xkme.2026.101412_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003088-200948050-00002","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride","volume":"48","author":"Padhi","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xkme.2026.101412_bib10","first-page":"181","article-title":"Cinacalcet hydrochloride (Sensipar)","volume":"18","author":"Poon","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"6","key":"10.1016\/j.xkme.2026.101412_bib11","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1007\/s00210-024-03705-4","article-title":"The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial","volume":"398","author":"Zhang","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101412_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/0886022X.2018.1562356","article-title":"The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism","volume":"41","author":"Susantitaphong","year":"2019","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.xkme.2026.101412_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2530162","article-title":"Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets","volume":"47","author":"Chao","year":"2025","journal-title":"Ren Fail"},{"issue":"11","key":"10.1016\/j.xkme.2026.101412_bib14","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.clinthera.2021.09.019","article-title":"A phase I, multiple-dose, randomized, double-blind, placebo-controlled study to evaluate pharmacokinetics, safety, and tolerability of etelcalcetide administered intravenously to Chinese patients with chronic kidney disease undergoing hemodialysis","volume":"43","author":"Xing","year":"2021","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.xkme.2026.101412_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0018578717733478","article-title":"Formulary drug review: etelcalcetide","volume":"52","author":"Baker","year":"2017","journal-title":"Hosp Pharm"},{"issue":"3","key":"10.1016\/j.xkme.2026.101412_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213774","article-title":"An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism","volume":"14","author":"Block","year":"2019","journal-title":"PLoS One"},{"issue":"1-4","key":"10.1016\/j.xkme.2026.101412_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000099190","article-title":"Stimulatory pathways of the Calcium-sensing receptor on acid secretion in freshly isolated human gastric glands","volume":"19","author":"Remy","year":"2007","journal-title":"Cell Physiol Biochem"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:14:37Z","timestamp":1786025677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2590059526001743"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101412","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101412"}}